Huntingtin's Function in Axonal Transport Is Conserved in Drosophila melanogaster

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Zala, Diana ^a,b,c   Hinckelmann, Maria Victoria ^a,b,c   Saudou, Frédéric ^a,b,c  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

^c INSERM U1005   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BRAIN DERIVED NEUROTROPHIC FACTOR; DYNEIN ADENOSINE TRIPHOSPHATASE; HUNTINGTIN; SYNAPTOTAGMIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL FRACTIONATION; CONTROLLED STUDY; DEPOLYMERIZATION; DROSOPHILA MELANOGASTER; HUMAN; HUMAN CELL; MICROTUBULE; MOTONEURON; NERVE CELL CULTURE; NERVE FIBER TRANSPORT; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SYNAPSE VESICLE; WESTERN BLOTTING;

ANIMALS; AXONAL TRANSPORT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL LINE; DROSOPHILA MELANOGASTER; DYNEINS; HUMANS; IMMUNOPRECIPITATION; MICROTUBULE-ASSOCIATED PROTEINS; MICROTUBULES; NEURONS; PROTEIN BINDING; RATS;

DROSOPHILA MELANOGASTER; MAMMALIA; RATTUS;

EID: 84875483055     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060162     Document Type: Article

References (55)

1. Reiter LT, Potocki L, Chien S, Gribskov M, Bier E, (2001) A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. Genome Res 11: 1114-1125.
2. Duffy JB, (2000) GAL4 system in Drosophila: a fly geneticist's Swiss army knife. Genesis 34: 1-15.
3. The Huntington's Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell 72: 971-983.
4. Steffan JS, Bodai L, Pallos J, Poelman M, McCampbell A, et al. (2001) Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413: 739-743.
5. Jackson GR, Salecker I, Dong X, Yao X, Arnheim N, et al. (1998) Polyglutamine-Expanded Human Huntingtin Transgenes Induce Degeneration of Drosophila Photoreceptor Neurons. Cell 21: 633-642.
6. Romero E, Cha G-H, Verstreken P, Ly C V, Hughes RE, et al. (2008) Suppression of neurodegeneration and increased neurotransmission caused by expanded full-length huntingtin accumulating in the cytoplasm. Neuron 57: 27-40.
7. Lee W-CM, Yoshihara M, Littleton JT, (2004) Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc Natl Acad Sci U S A 101: 3224-3229.
8. Marsh JL, Pallos J, Thompson LM (2003) Fly models of Huntington's disease. Hum Mol Genet 12 Spec No: R187-93.
9. Branco J, Al-Ramahi I, Ukani L, Pérez AM, Fernandez-Funez P, et al. (2008) Comparative analysis of genetic modifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum Mol Genet 17: 376-390.
10. Agrawal N, Pallos J, Slepko N, Apostol BL, Bodai L, et al. (2005) Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. Proc Natl Acad Sci U S A 102: 3777-3781.
11. Kazemi-Esfarjani P, Benzer S, (2000) Genetic suppression of polyglutamine toxicity in Drosophila. Science 287: 1837-1840.
12. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, et al. (2004) SUMO Modification of Huntingtin and Huntington's Disease Pathology. Science 304: 100-104.
13. Schulte J, Sepp KJ, Wu C, Hong P, Littleton JT, (2011) High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model. PLoS One 6: e23841.
14. Kaltenbach LS, Romero E, Becklin RR, Chettier R, Bell R, et al. (2007) Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration. PLoS Genet 3: e82.
15. Ravikumar B, Vacher C, Berger Z, Davies JE, Luo S, et al. (2004) Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat Genet 36: 585-595 doi:10.1038/ng1362.
16. Borrell-Pagès M, Zala D, Humbert S, Saudou F, (2006) Human Genome & Diseases?: Review Huntington's disease?: from huntingtin function and dysfunction to therapeutic strategies. Cell Mol Life Sci 63: 2642-2660.
17. Schulte J, Littleton JT, (2011) The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. Curr Trends Neurol 5: 65-78.
18. Zuccato C, Valenza M, Cattaneo E, (2010) Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol Rev 90: 905-981.
19. Dragatsis I, Levine MS, Zeitlin S, (2000) Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet 26: 300-306.
20. Goehler H, Lalowski M, Stelzl U, Waelter S, Stroedicke M, et al. (2004) A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. Mol Cell 15: 853-865.
21. Shirasaki DI, Greiner ER, Al-Ramahi I, Gray M, Boontheung P, et al. (2012) Network organization of the huntingtin proteomic interactome in Mammalian brain. Neuron 75: 41-57.
22. Gauthier LR, Charrin BC, Borrell-Pagès M, Dompierre JP, Rangone H, et al. (2004) Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell 118: 127-138.
23. Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur ELF (2007) Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A: 10045-10050.
24. Gunawardena S, Her L, Brusch RG, Laymon RA, Niesman IR, et al. (2003) Disruption of Axonal Transport by Loss of Huntingtin or Expression of Pathogenic PolyQ Proteins in Drosophila. Neuron 40: 25-40.
25. Colin E, Zala D, Liot G, Rangone H, Borrell-Pagès M, et al. (2008) Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J 27: 1-11.
26. Zhang S, Feany MB, Saraswati S, Littleton JT, Perrimon N, (2009) Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model. Dis Model Mech 2: 247-266.
27. Power D, Srinivasan S, Gunawardena S, (2012) In-vivo evidence for the disruption of Rab11 vesicle transport by loss of huntingtin. Neuroreport 23: 970-977.
28. Zhang YQ, Rodesch CK, Broadie K, (2002) Living synaptic vesicle marker: synaptotagmin-GFP. Genesis 34: 142-145.
29. Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, et al. (2010) Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Neuron 67: 392-406.
30. Saudou F, Finkbeiner S, Devys D, Greenberg ME, (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66.
31. Zala D, Hinckelmann M-V, Yu H, Menezes Lyra da Cunha M, Liot G, et al. (2013) Vesicular Glycolysis Provides On-board Energy for Fast Axonal Transport. Cell 152: 479-491.
32. Liot G, Zala D, Pla P, Mottet G, Piel M, et al. (2013) Mutant huntingtin alters retrograde transport of TrkB receptors in striatal dendrites. J Neurosci In press.
33. Li SH, Gutekunst CA, Hersch SM, Li XJ, (1998) Interaction of huntingtin-associated protein with dynactin P150Glued. J Neurosci 18: 1261-1269.
34. Engelender S, Sharp AH, Colomer V, Tokito MK, Lanahan A, et al. (1997) Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. Hum Mol Genet 6: 2205-2212.
35. Mcguire JR, Rong J, Li S-H, Li X, (2006) Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular traffiking in neurons. J Biol Chem 150: 3552-3559.
36. Zala D, Colin E, Rangone H, Liot G, Humbert S, et al. (2008) Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet 17: 3837-3846.
37. Pineda JR, Pardo R, Zala D, Yu H, Humbert S, et al. (2009) Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Mol Brain 11: 1-11.
38. Pardo R, Molina-Calavita M, Poizat G, Keryer G, Humbert S, et al. (2010) pARIS-htt: an optimised expression platform to study huntingtin reveals functional domains required for vesicular trafficking. Mol Brain 3: 17-23.
39. Her L, Goldstein LSB, (2008) Enhanced Sensitivity of Striatal Neurons to Axonal Transport Defects Induced by Mutant Huntingtin. J Neurosci 28: 13662-13672.
40. Altar CA, Cai N, Bliven T, Juhasz M, Conner JM, et al. (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389: 856-860.
41. Taylor AM, Blurton-Jones M, Rhee SW, Cribbs DH, Cotman CW, et al. (2005) A microfluidic culture platform for CNS axonal injury, regeneration and transport. Nat Methods 2: 599-605.
42. Kwinter DM, Lo K, Mafi P, Silverman MA, (2009) Dynactin regulates bidirectional transport of dense-core vesicles in the axon and dendrites of cultured hippocampal neurons. Neuroscience 162: 1001-1010.
43. Kuznicki ML, Gunawardena S (2010) In vivo visualization of synaptic vesicles within Drosophila larval segmental axons. J Vis Exp 44.
44. Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, et al. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127: 59-69.
45. Dunah AW, Jeong H, Griffin A, Kim Y, Standaert DG, et al. (2002) Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease. Science 296: 2238-2243.
46. Li S-H, Cheng AL, Zhou H, Lam S, Rao M, et al. (2002) Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol 22: 1277-1287.
47. Gervais FG, Singaraja R, Xanthoudakis S, Gutekunst C, Leavitt BR, et al. (2002) Recruitment and activation of caspase- 8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nat Cell Biol 4: 95-105.
48. Vecchi M, Di Fiore PP, (2005) It's HIP to be a hub: new trends for old-fashioned proteins. J Cell Biol 170: 169-171.
49. Keryer G, Pineda JR, Liot G, Kim J, Dietrich P, et al. (2011) Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease. J Clin Invest 121: 4372-4382.
50. Caviston JP, Holzbaur ELF (2009) Huntingtin as an essential integrator of intracellular vesicular trafficking. Trends Cell Biol: 1-9.
51. Dragatsis I, Efstratiadis A, Zeitlin S, (1998) Mouse mutant embryos lacking huntingtin are rescued from lethality by wild-type extraembryonic tissues. Development 125: 1529-1539.
52. Wheeler VC, Gutekunst C-A, Vrbanac V, Lebel L-A, Schilling G, et al. (2002) Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in mice. Hum Mol Genet 11: 633-640.
53. Szebenyi G, Morfini GA, Babcock A, Gould M, Selkoe K, et al. (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40: 41-52.
54. Zeitlin S, Liu JP, Chapman DL, Papaioannou VE, Efstratiadis A, (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nat Genet 11: 155-163.
55. Van Raamsdonk JM, Pearson J, Murphy Z, Hayden MR, Leavitt BR, (2006) Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease. BMC Neurosci 7: 80.